clofibrate has been researched along with Arteriosclerosis Obliterans in 7 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a pilot study the therapeutic effect of 2 x 500 mg etofibrate (Lipo Merz retard) on lipids and lipoproteins, fibrinolytic activity and clinical parameters was studied for four weeks in hyperlipidemic patients suffering from arteriosclerosis obliterans (Fontaine stage II/III)." | 7.67 | [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. ( Basista, M; Bieroń, K; Czarnecka, H; Dembińska-Kieć, A; Grodzińska, L; Kedzior, A; Kostka-Trabka, E; Slawiński, M; Trabka, E; Zmuda, A, 1989) |
| "In a pilot study the therapeutic effect of 2 x 500 mg etofibrate (Lipo Merz retard) on lipids and lipoproteins, fibrinolytic activity and clinical parameters was studied for four weeks in hyperlipidemic patients suffering from arteriosclerosis obliterans (Fontaine stage II/III)." | 3.67 | [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. ( Basista, M; Bieroń, K; Czarnecka, H; Dembińska-Kieć, A; Grodzińska, L; Kedzior, A; Kostka-Trabka, E; Slawiński, M; Trabka, E; Zmuda, A, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BARNETT, AJ | 1 |
| CARSON, V | 1 |
| DE MEIRING, PV | 1 |
| Coffman, JD | 1 |
| Rasmussen, HM | 1 |
| Bagliani, A | 1 |
| Borri, P | 1 |
| Parravicini, R | 1 |
| Dembińska-Kieć, A | 1 |
| Kostka-Trabka, E | 1 |
| Grodzińska, L | 1 |
| Bieroń, K | 1 |
| Kedzior, A | 1 |
| Basista, M | 1 |
| Zmuda, A | 1 |
| Trabka, E | 1 |
| Slawiński, M | 1 |
| Czarnecka, H | 1 |
| Sznajderman, M | 1 |
| Kancelarczyk, WL | 1 |
| Stăncioiu, N | 1 |
| Scrobohaci, L | 1 |
| Fearnley, GR | 1 |
1 trial available for clofibrate and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
The peripheral circulation and treatment of hyperlipoproteinemias.
Topics: Adult; Aged; Arteriosclerosis Obliterans; Blood Circulation; Clofibrate; Colestipol; Female; Humans; | 1983 |
6 other studies available for clofibrate and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
"ATROMID" IN ATHEROSCLEROSIS.
Topics: Androsterone; Angina Pectoris; Arteriosclerosis Obliterans; Atherosclerosis; Blood Chemical Analysis | 1964 |
[Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Carbamates; Chronic Disease; Clofibrate; Drug Combinations | 1975 |
[Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans].
Topics: Adult; Arteriosclerosis Obliterans; Cholesterol, HDL; Clofibrate; Clofibric Acid; Female; Humans; Hy | 1989 |
[Leg blood supply in patients with arteriosclerosis obliterans and primary disorders of lipid metabolism after hypolipemic treatment].
Topics: Arteriosclerosis Obliterans; Clofibrate; Dietary Fats; Humans; Hyperlipidemias; Leg; Middle Aged; Re | 1988 |
[Treatment with Atromid "S" in arteriosclerosis obliterans].
Topics: Adult; Arteriosclerosis Obliterans; Clofibrate; Female; Humans; Male; Middle Aged | 1972 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation | 1971 |